Speaker at Pharmaceutics and Drug Delivery Systems 2022 - Deepika Raina
Graphic Era Hill University, India
Title : Formulation and evaluation of Escitalopram loaded bio nanosuspension for brain specificity.

Abstract:

In the United States, it is estimated that depression costs the country over $210 billion each year in lost productivity, health care costs, and absenteeism. It is estimated that between 1 and 3 percent of adults suffer from depression, while about 6 percent suffer from major depression at some point in their lives. While antidepressants are not universally effective yet, research is revealing important information about their use that may help to limit the limitations of the current treatment approach. In the current research, nanoformulation was formulated with a novel biopolymer. Because of their unique shape, nanoparticles are not usually absorbed by the body on their own. ten formulations were prepared to vary the polymer ratio. The prepared formulation was evaluated for content uniformity, pH, in-vitro drug release Ex-vivo, and stability. The results revealed that the (1: 1) ratio was the best formulation on the basis of the response obtained.

Biography:

Dr. Deepika Raina studied B. Pharmacy at the RKGIT Ghaziabad, India and graduated in 2009. I then joined the research group of Prof. Satheesh Madhav at the DIT University, India. I received my PhD degree in 2018 at the same institution. In 2018 I was appointed as an Assistant Professor at DIT University,  and then joined Chitkara University Punjab. Currently I am working as an Associate Professor in Graphic Era Hill University. I have published more than 15 research articles out of which 5 of them are indexed in SCI(E) or scopus journals.

Watsapp